Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.98%
0%
1.98%
6 Months
18.76%
0%
18.76%
1 Year
19.24%
0%
19.24%
2 Years
-2.63%
0%
-2.63%
3 Years
-31.59%
0%
-31.59%
4 Years
-36.52%
0%
-36.52%
5 Years
-39.9%
0%
-39.9%
Assura Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.72%
EBIT Growth (5y)
10.13%
EBIT to Interest (avg)
3.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.15%
Dividend Payout Ratio
63.88%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.24%
ROE (avg)
5.50%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.97
EV to EBIT
9.94
EV to EBITDA
9.94
EV to Capital Employed
0.96
EV to Sales
8.24
PEG Ratio
NA
Dividend Yield
628.01%
ROCE (Latest)
9.70%
ROE (Latest)
12.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
185.50
159.90
16.01%
Operating Profit (PBDIT) excl Other Income
154.00
131.70
16.93%
Interest
43.80
29.30
49.49%
Exceptional Items
57.90
-131.50
144.03%
Consolidate Net Profit
166.00
-28.80
676.39%
Operating Profit Margin (Excl OI)
828.60%
821.80%
0.68%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 16.01% vs 5.20% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 676.39% vs 75.84% in Mar 2024
About Assura Plc 
Assura Plc
Realty
Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company's property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston. The Company's subsidiaries include Abbey Healthcare Group Ltd, Abbey Healthcare Property Investments Ltd, Assura Aspire Ltd, Assura Aspire UK Ltd, Assura HC UK Ltd, Assura Primary Care Properties Ltd and Assura Trellech Ltd.
Company Coordinates 
Company Details
The Brew House, Greenalls Avenue , WARRINGTON None : WA4 6HL
Registrar Details






